Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Savara Pharmaceuticals
3267
Savara Pharmaceuticals
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection inCystic Fibrosis
Suggest edits
Type
B2c
Founded
2007
Raised
$103.9M
Follow us
Also headquartered in Austin
AMD
SXSW
Gigaom
SolarWinds
OpenStack
2FA, Inc.
Vista Equity Partners
Whole Foods Market
BigCommerce
HomeAway
Companies in the same industry
Rodin Therapeutics
Xceleron (Chapter 11)
Impedans
Turing Pharmaceuticals
Aptuit
Mereo BioPharma
Plex Pharmaceuticals
BIOXIS Pharmaceuticals
Sothic Bioscience Limited
Endoceutics
Alexa global traffic share
Overview
Funding
6
Add info
Latest funding
Show all
$47,000,000
Post-IPO equity - 2017
$15,000,000
Debt financing - 2017
Silicon Valley Bank
Team Size
2
Employees
I work here
Location
Austin
,
United States
Headquarters
Explore Austin
$15,000,000
Debt financing
texastechpulse
Savara Gets $15M In Debt Funding From SVB
Xconomy
Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates
Health
$20,000,000
Venture capital (Series C)
FinSMEs
,
Xconomy
Savara Pharmaceuticals Closes $20M Series C Financing
Health
Funding
